CA2343713A1 - Utilisation de pex dans le traitement de maladies metaboliques des os - Google Patents

Utilisation de pex dans le traitement de maladies metaboliques des os Download PDF

Info

Publication number
CA2343713A1
CA2343713A1 CA002343713A CA2343713A CA2343713A1 CA 2343713 A1 CA2343713 A1 CA 2343713A1 CA 002343713 A CA002343713 A CA 002343713A CA 2343713 A CA2343713 A CA 2343713A CA 2343713 A1 CA2343713 A1 CA 2343713A1
Authority
CA
Canada
Prior art keywords
bone diseases
metabolic bone
pex
treatment
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002343713A
Other languages
English (en)
Other versions
CA2343713C (fr
Inventor
Andrew C. Karaplis
David Goltzman
Mark L. Lipman
Janet E. Henderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002245903A external-priority patent/CA2245903A1/fr
Application filed by Individual filed Critical Individual
Priority to CA002343713A priority Critical patent/CA2343713C/fr
Publication of CA2343713A1 publication Critical patent/CA2343713A1/fr
Application granted granted Critical
Publication of CA2343713C publication Critical patent/CA2343713C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002343713A 1998-09-28 1999-09-27 Utilisation de pex dans le traitement de maladies metaboliques des os Expired - Fee Related CA2343713C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002343713A CA2343713C (fr) 1998-09-28 1999-09-27 Utilisation de pex dans le traitement de maladies metaboliques des os

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA002245903A CA2245903A1 (fr) 1998-09-28 1998-09-28 Utilisation de pex dans le traitement des maladies osseuses metaboliques
CA2,245,903 1998-09-28
PCT/CA1999/000895 WO2000018954A2 (fr) 1998-09-28 1999-09-27 Utilisation de pex dans le traitement de maladies metaboliques des os
CA002343713A CA2343713C (fr) 1998-09-28 1999-09-27 Utilisation de pex dans le traitement de maladies metaboliques des os

Publications (2)

Publication Number Publication Date
CA2343713A1 true CA2343713A1 (fr) 2000-04-06
CA2343713C CA2343713C (fr) 2008-01-08

Family

ID=25680440

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002343713A Expired - Fee Related CA2343713C (fr) 1998-09-28 1999-09-27 Utilisation de pex dans le traitement de maladies metaboliques des os

Country Status (1)

Country Link
CA (1) CA2343713C (fr)

Also Published As

Publication number Publication date
CA2343713C (fr) 2008-01-08

Similar Documents

Publication Publication Date Title
WO2000018954A3 (fr) Utilisation de pex dans le traitement de maladies metaboliques des os
AU1726797A (en) A method for monitoring the health of a patient by measuring and predicting the glucose level of the patient's blood sample
WO2002040634A3 (fr) Minireseaux d'expression et leurs utilisations
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
WO2004020968A3 (fr) Mutations de nod2 associees a la stenose fibreuse chez des patients souffrant de la maladie de crohn
EP0808324A4 (fr) Compositions destinees au traitement et au diagnostic de maladies cardio-vasculaires et techniques correspondantes
CA2421007A1 (fr) Procede de detection, dans du plasma ou du serum, d'arn associe a des telomerases htr et htert
CA2387390A1 (fr) Elisa pour facteur de croissance endotheliale
AU2003295987A1 (en) System and method for automatic diagnosis of patient health
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
CA2263063A1 (fr) Methode pour diagnostiquer et distinguer les accidents vasculaires cerebraux et dispositifs de diagnostic utilises a cette fin
UA86582C2 (ru) Способ лечения хореи гентингтона ейкозапентеновой кислотой
WO2003024308A3 (fr) Procedes permettant d'analyser le facteur de croissance du tissu conjonctif
WO1995024650A3 (fr) Procedes de diagnostic et de traitement de l'eclampsisme
MXPA01011182A (es) Metodos, composiciones y conjuntos para indicador biologico de esterilizacion.
WO2002022871A3 (fr) Gene humain de l'osteoporose
PT1416965E (pt) Método de ensaio para a doença de alzheimer
AU5153398A (en) Diagnostic method for the detection of alzheimer's disease in living patients
CA2343713A1 (fr) Utilisation de pex dans le traitement de maladies metaboliques des os
AU1153300A (en) Methods of diagnosing or prognosing alzheimer's disease
AU1820499A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU4753900A (en) Methods of diagnosing or treating alzheimer's disease
WO2003065871A3 (fr) Methodes et compositions permettant de traiter les troubles hematologiques au moyen des molecules 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 ou 13249
AU5103096A (en) Use of ferrites for determining the perfusion of human tissue by m.r. diagnosis
WO2005030265A3 (fr) Imagerie optique d'une endometriose

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20150928